All News #Library
Biotech
Atreca axes lead drug, 40% of staff in last-ditch pivot to ADCs
11 Aug 2023 //
FIERCE BIOTECH
Atreca Reports Second Quarter 2023 Financial Results
10 Aug 2023 //
GLOBENEWSWIRE
Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101
05 Jun 2023 //
GLOBENEWSWIRE
Atreca Announces Oral Presentation of ATRC-101 Phase 1b Study Data at 2023 ASCO
26 Apr 2023 //
GLOBENEWSWIRE
Atreca and Xencor to Develop T Cell Engaging Bispecific Antibody
06 Feb 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support